ClinicalTrials.Veeva

Menu
O

Oculus Research Inc. | Raleigh, NC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

RGN-259
Atropine
iodine
Povidone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)

Enrolling
Neurotrophic Keratopathy
Drug: Placebo
Drug: RGN-259

This study evaluates the progression of myopia in participants using microdosed atropine 0.01%, atropine 0.1%, or placebo ophthalmic solution. Eligib...

Active, not recruiting
Myopia
Drug: Placebo Ophthalmic Solution
Drug: Atropine 0.01% Ophthalmic Solution

Trial sponsors

Bausch + Lomb logo
E
R
Shire logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems